Ozempic manufacturer Novo Nordisk spent $11 million last year 'wining and dining' doctors. Experts slam the move as a breach of doctor-patient trust

Do pharmaceutical companies have influence over your doctor's prescription pad? It's relatively easy to check—but you shouldn't have to, experts say. Read More